Breaking News Headlines Today | Ground News

See every side of every news story

Herald-citizen.com image

News from herald-citizen.com

Herald-citizen.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Herald-citizen.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Herald-citizen.com

Where is Herald-citizen.com located?Herald-citizen.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Herald-citizen.com News

Canadian PM Carney visits Trump as relations between the longtime allies sit at a low point — President Donald Trump greets Prime Minister of Canada Mark Carney at the West Wing entrance of the White House (54502389070) by Wikipedia Photo - https://www.flickr.com/photos/202101414@N05/54502389070/ (By: The White House) / Creative Commons

U.S.-Canada Relations · Canada

Canadian PM Carney visits Trump as relations between the longtime allies sit at a low point

46% Center coverage: 145 sources

Ottawa has tempered expectations, but pressure is mounting on the government to deliver measurable progress on trade See the Story

CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology

Shanghai, China · Shanghai

CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology

63% Center coverage: 19 sources

SHANGHAI, Oct. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of CT071 (an autologous CAR T-cell product targeting GPRC5D) for the treatment of relapsed/refractory…See the Story

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment

Bennington · Bennington

Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment

56% Center coverage: 16 sources

HMI-115 demonstrated statistically significant improvement in endometriosis pain See the Story

Breaking News Topics Related to Herald-citizen.com